CERVICAL CANCER BY FIGO STAGE 2018
Clinical trials for CERVICAL CANCER BY FIGO STAGE 2018 explained in plain language.
Never miss a new study
Get alerted when new CERVICAL CANCER BY FIGO STAGE 2018 trials appear
Sign up with your email to follow new studies for CERVICAL CANCER BY FIGO STAGE 2018, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to stop cervical cancer return
Disease control Not yet recruitingThis phase II trial tests whether adding pembrolizumab and lenvatinib to standard chemoradiation and brachytherapy can improve outcomes for adults with high-risk locally advanced cervical cancer. About 87 participants will receive the drug combination and be followed for two year…
Matched conditions: CERVICAL CANCER BY FIGO STAGE 2018
Phase: PHASE2 • Sponsor: Prof. Dr. Remi A. Nout • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New radiation technique aims to prevent dangerous blood drops in cervical cancer patients
Symptom relief Not yet recruitingThis study tests whether a new way of planning radiation—sparing the pelvic and lower spine bones—can lower the risk of severe blood-related side effects in women with advanced cervical cancer. About 72 participants will receive standard chemoradiotherapy, but half will have thei…
Matched conditions: CERVICAL CANCER BY FIGO STAGE 2018
Phase: NA • Sponsor: Institut Paoli-Calmettes • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC